These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1494 related articles for article (PubMed ID: 32882920)

  • 1. Applications and Limitations of Dendrimers in Biomedicine.
    Chis AA; Dobrea C; Morgovan C; Arseniu AM; Rus LL; Butuca A; Juncan AM; Totan M; Vonica-Tincu AL; Cormos G; Muntean AC; Muresan ML; Gligor FG; Frum A
    Molecules; 2020 Sep; 25(17):. PubMed ID: 32882920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells.
    He X; Alves CS; Oliveira N; Rodrigues J; Zhu J; Bányai I; Tomás H; Shi X
    Colloids Surf B Biointerfaces; 2015 Jan; 125():82-9. PubMed ID: 25437067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubility enhancement of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) using polypolypropylene oxide core PAMAM dendrimers.
    Koç FE; Senel M
    Int J Pharm; 2013 Jul; 451(1-2):18-22. PubMed ID: 23628406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug delivery investigations of quaternised poly(propylene imine) dendrimer using nimesulide as a model drug.
    Murugan E; Geetha Rani DP; Yogaraj V
    Colloids Surf B Biointerfaces; 2014 Feb; 114():121-9. PubMed ID: 24184533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study on solubility improvement of tetracycline and dexamethasone by poly(propylene imine) and polyamidoamine dendrimers: An insight into cytotoxicity and cell proliferation.
    Najafi F; Salami-Kalajahi M; Roghani-Mamaqani H; Kahaie-Khosrowshahi A
    J Biomed Mater Res A; 2020 Mar; 108(3):485-495. PubMed ID: 31682311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polypropyleneimine and polyamidoamine dendrimer mediated enhanced solubilization of bortezomib: Comparison and evaluation of mechanistic aspects by thermodynamics and molecular simulations.
    Chaudhary S; Gothwal A; Khan I; Srivastava S; Malik R; Gupta U
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():611-619. PubMed ID: 28024628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of anionic half generation 3.5-6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin.
    Kirkpatrick GJ; Plumb JA; Sutcliffe OB; Flint DJ; Wheate NJ
    J Inorg Biochem; 2011 Sep; 105(9):1115-22. PubMed ID: 21704583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical studies of dendrimer prodrugs.
    Kojima C
    Expert Opin Drug Metab Toxicol; 2015; 11(8):1303-15. PubMed ID: 26028253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-Assembling Supramolecular Dendrimers for Biomedical Applications: Lessons Learned from Poly(amidoamine) Dendrimers.
    Lyu Z; Ding L; Tintaru A; Peng L
    Acc Chem Res; 2020 Dec; 53(12):2936-2949. PubMed ID: 33275845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendrimers as versatile platform in drug delivery applications.
    Svenson S
    Eur J Pharm Biopharm; 2009 Mar; 71(3):445-62. PubMed ID: 18976707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin-Based Organoiron Dendrimers as Promising Anti-Inflammatory, Anticancer, and Antimicrobial Drugs.
    Abd-El-Aziz AS; Benaaisha MR; Abdelghani AA; Bissessur R; Abdel-Rahman LH; Fayez AM; El-Ezz DA
    Biomolecules; 2021 Oct; 11(11):. PubMed ID: 34827566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One platform comparison of solubilization potential of dendrimer with some solubilizing agents.
    Jain S; Kesharwani P; Tekade RK; Jain NK
    Drug Dev Ind Pharm; 2015 May; 41(5):722-7. PubMed ID: 24641446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(amidoamine) Dendrimers as Nanocarriers for 5-Fluorouracil: Effectiveness of Complex Formation and Cytotoxicity Studies.
    Szota M; Reczyńska-Kolman K; Pamuła E; Michel O; Kulbacka J; Jachimska B
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendrimer-TPGS mixed micelles for enhanced solubility and cellular toxicity of taxanes.
    Pooja D; Kulhari H; Singh MK; Mukherjee S; Rachamalla SS; Sistla R
    Colloids Surf B Biointerfaces; 2014 Sep; 121():461-8. PubMed ID: 25063311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(amidoamine) dendrimer complexes as a platform for gene delivery.
    Shcharbin D; Shakhbazau A; Bryszewska M
    Expert Opin Drug Deliv; 2013 Dec; 10(12):1687-98. PubMed ID: 24168461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional lactobionic acid-modified dendrimers for targeted drug delivery to liver cancer cells: investigating the role played by PEG spacer.
    Fu F; Wu Y; Zhu J; Wen S; Shen M; Shi X
    ACS Appl Mater Interfaces; 2014 Sep; 6(18):16416-25. PubMed ID: 25185074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity and proapoptotic activity of poly(propylene imine) glycodendrimers in vitro: considering their contrary potential as biocompatible entity and drug molecule in cancer.
    Ziemba B; Franiak-Pietryga I; Pion M; Appelhans D; Muñoz-Fernández MÁ; Voit B; Bryszewska M; Klajnert-Maculewicz B
    Int J Pharm; 2014 Jan; 461(1-2):391-402. PubMed ID: 24361266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polypropylene imine dendrimer mediated solubility enhancement: effect of pH and functional groups of hydrophobes.
    Gupta U; Agashe HB; Jain NK
    J Pharm Pharm Sci; 2007; 10(3):358-67. PubMed ID: 17727799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigations on the toxicological profile of functionalized fifth-generation poly (propylene imine) dendrimer.
    Agashe HB; Dutta T; Garg M; Jain NK
    J Pharm Pharmacol; 2006 Nov; 58(11):1491-8. PubMed ID: 17132212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complexes of Indomethacin with 4-Carbomethoxy-pyrrolidone PAMAM Dendrimers Show Improved Anti-inflammatory Properties and Temperature-Dependent Binding and Release Profile.
    Ficker M; Theeuwen MJM; Janaszewska A; Gorzkiewicz M; Svenningsen SW; Klajnert-Maculewicz B; Christensen JB
    Mol Pharm; 2018 Aug; 15(8):3573-3582. PubMed ID: 30011214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 75.